Home › Billing code Q0221
Q0221
Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 600 mg
Medicaid paid $11K on code Q0221 from 2018 through 2024, to 12 providers — the #7,753 code in the file by dollars. 98% of it was billed in Virginia.
28Total paid$11K
24GClaims684
Paid per claim line$15.68
33Providers billing it12
Box 32 · Location
Where Q0221 is billed
The largest of 7 states and territories, by the billing provider's address. States cover different services and set their own rates, so the same code can mean different things in different programs.
Ranked
Top providers billing Q0221
| # | Provider | Location | Claims | Paid on Q0221 |
|---|---|---|---|---|
| 1 | Virginia Commonwealth University Health System Authority | Richmond, VA | 284 | $10K |
| 2 | University of Utah | Salt Lake City, UT | 16 | $235.30 |
| 3 | Cooperman Barnabas Medical Center INC | Livingston, NJ | 16 | $2.00 |
| 4 | University of Washington | Seattle, WA | 79 | $0.26 |
| 5 | Harborview Medical Center | Seattle, WA | 42 | $0.20 |
| 6 | Fred Hutchinson Cancer Center | Seattle, WA | 30 | $0.11 |
| 7 | Henry Ford Health System | Detroit, MI | 13 | $0.00 |
| 8 | Regents of the University of Michigan | Ann Arbor, MI | 19 | $0.00 |
| 9 | The General Hospital Corporation | Boston, MA | 12 | $0.00 |
| 10 | Beth Israel Deaconess Medical Center, INC. | Boston, MA | 93 | $0.00 |
| 11 | Medical University Hospital Authority | Charleston, SC | 20 | $0.00 |
| 12 | Boston Medical Center Corporation | Boston, MA | 60 | $0.00 |